DexCom Inc. (DXCM): Price and Financial Metrics
DXCM Price/Volume Stats
| Current price | $86.67 | 52-week high | $118.80 |
| Prev. close | $85.74 | 52-week low | $57.52 |
| Day low | $85.83 | Volume | 2,398,739 |
| Day high | $87.91 | Avg. volume | 4,016,117 |
| 50-day MA | $76.21 | Dividend yield | N/A |
| 200-day MA | $76.35 | Market Cap | 33.98B |
DXCM Stock Price Chart Interactive Chart >
DexCom Inc. (DXCM) Company Bio
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second generation product, the Seven Continuous Glucose Monitoring System in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment. (Source:Wikipedia)
DXCM Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DXCM Price Returns
| 1-mo | 3.98% |
| 3-mo | 11.34% |
| 6-mo | 11.52% |
| 1-year | -24.83% |
| 3-year | 12.41% |
| 5-year | -4.89% |
| YTD | 11.44% |
| 2024 | -37.33% |
| 2023 | 9.58% |
| 2022 | -15.64% |
| 2021 | 45.23% |
| 2020 | 69.02% |